BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 18820297)

  • 1. Regulation of the catalytic function of topoisomerase II alpha through association with RNA.
    Park SW; Parrott AM; Fritz DT; Park Y; Mathews MB; Lee CG
    Nucleic Acids Res; 2008 Nov; 36(19):6080-90. PubMed ID: 18820297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RNA helicase A interacts with dsDNA and topoisomerase IIalpha.
    Zhou K; Choe KT; Zaidi Z; Wang Q; Mathews MB; Lee CG
    Nucleic Acids Res; 2003 May; 31(9):2253-60. PubMed ID: 12711669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HU-331 is a catalytic inhibitor of topoisomerase IIα.
    Regal KM; Mercer SL; Deweese JE
    Chem Res Toxicol; 2014 Dec; 27(12):2044-51. PubMed ID: 25409338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The p53 tumor suppressor stimulates the catalytic activity of human topoisomerase IIalpha by enhancing the rate of ATP hydrolysis.
    Kwon Y; Shin BS; Chung IK
    J Biol Chem; 2000 Jun; 275(24):18503-10. PubMed ID: 10764786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGB1 interacts with human topoisomerase IIalpha and stimulates its catalytic activity.
    Stros M; Bacíková A; Polanská E; Stokrová J; Strauss F
    Nucleic Acids Res; 2007; 35(15):5001-13. PubMed ID: 17636313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of human topoisomerase IIalpha expression correlates with relative amounts of specificity factors Sp1 and Sp3 bound at proximal and distal promoter regions.
    Williams AO; Isaacs RJ; Stowell KM
    BMC Mol Biol; 2007 May; 8():36. PubMed ID: 17511886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RECQL5 cooperates with Topoisomerase II alpha in DNA decatenation and cell cycle progression.
    Ramamoorthy M; Tadokoro T; Rybanska I; Ghosh AK; Wersto R; May A; Kulikowicz T; Sykora P; Croteau DL; Bohr VA
    Nucleic Acids Res; 2012 Feb; 40(4):1621-35. PubMed ID: 22013166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BRCA1-mediated ubiquitination inhibits topoisomerase II alpha activity in response to oxidative stress.
    Shinagawa H; Miki Y; Yoshida K
    Antioxid Redox Signal; 2008 May; 10(5):939-49. PubMed ID: 18162055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of toposome, a novel multisubunit complex containing topoisomerase IIalpha.
    Lee CG; Hague LK; Li H; Donnelly R
    Cell Cycle; 2004 May; 3(5):638-47. PubMed ID: 15034300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fbxo28 promotes mitotic progression and regulates topoisomerase IIα-dependent DNA decatenation.
    Kratz AS; Richter KT; Schlosser YT; Schmitt M; Shumilov A; Delecluse HJ; Hoffmann I
    Cell Cycle; 2016 Dec; 15(24):3419-3431. PubMed ID: 27754753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase C delta activates topoisomerase IIalpha to induce apoptotic cell death in response to DNA damage.
    Yoshida K; Yamaguchi T; Shinagawa H; Taira N; Nakayama KI; Miki Y
    Mol Cell Biol; 2006 May; 26(9):3414-31. PubMed ID: 16611985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificity plays an important role in uncoupling the catalytic and scaffolding activities of rat testis DNA topoisomerase IIalpha.
    Bakshi R; Galande S; Muniyappa K
    J Biomol Struct Dyn; 2001 Apr; 18(5):749-60. PubMed ID: 11334111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-Mechanism Model for the Interaction of Etoposide Quinone with Topoisomerase IIα.
    Gibson EG; King MM; Mercer SL; Deweese JE
    Chem Res Toxicol; 2016 Sep; 29(9):1541-8. PubMed ID: 27533850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the C-terminal domain of topoisomerase IIalpha on the DNA cleavage activity of the human enzyme.
    Dickey JS; Osheroff N
    Biochemistry; 2005 Aug; 44(34):11546-54. PubMed ID: 16114891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel xanthone-polyamine conjugates as catalytic inhibitors of human topoisomerase IIα.
    Minniti E; Byl JAW; Riccardi L; Sissi C; Rosini M; De Vivo M; Minarini A; Osheroff N
    Bioorg Med Chem Lett; 2017 Oct; 27(20):4687-4693. PubMed ID: 28919339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All-trans retinoic acid suppresses topoisomerase IIα through the proteasomal pathway.
    Li X; Li Y; Shen X; Fu S; Han S; Feng Q
    Anticancer Drugs; 2015 Aug; 26(7):737-46. PubMed ID: 25946380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGCG regulates the cross-talk between JWA and topoisomerase IIα in non-small-cell lung cancer (NSCLC) cells.
    Li Y; Shen X; Wang X; Li A; Wang P; Jiang P; Zhou J; Feng Q
    Sci Rep; 2015 Jun; 5():11009. PubMed ID: 26046674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sodium salicylate is a novel catalytic inhibitor of human DNA topoisomerase II alpha.
    Bau JT; Kurz EU
    Biochem Pharmacol; 2011 Feb; 81(3):345-54. PubMed ID: 20959117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of the Impact of Copper(II) α-(N)-Heterocyclic Thiosemicarbazone Complexes on DNA Topoisomerase IIα.
    Wilson JT; Jiang X; McGill BC; Lisic EC; Deweese JE
    Chem Res Toxicol; 2016 Apr; 29(4):649-58. PubMed ID: 26982206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene regulation and priming by topoisomerase IIα in embryonic stem cells.
    Thakurela S; Garding A; Jung J; Schübeler D; Burger L; Tiwari VK
    Nat Commun; 2013; 4():2478. PubMed ID: 24072229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.